DR. SURESH CHARI
Cleveland Mayo Clinic
Suresh Chari, M.D. is a Professor of Medicine at the Mayo Clinic College of Medicine. He is also a consultant in the Division of Gastroenterology. He is Head of the Pancreas Interest Group in the Division of Gastroenterology and Hepatology. Dr. Chari has a broad interest in diseases of the pancreas and his NIH-funded research focuses on the role of diabetes and hyperglycemia as a marker of undiagnosed pancreatic cancer. Additional areas of clinical research involve understanding the clinical spectrum of autoimmune pancreatitis and he is also interested in cystic tumors of the pancreas including their classification, prevalence, and natural history.
William K. Oh
Chief, Division of Hematology and Medical Oncology
Ezra M. Greenspan, MD Professor in Clinical Cancer Therapeutics
Icahn School of Medicine at Mount Sinai
Dr. William Oh, an expert in the management of genitourinary malignancies, including prostate, renal, bladder and testicular cancers, is Chief of the Division of Hematology and Medical Oncology and Associate Director for Clinical Research for The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. Tisch Cancer Institute received the prestigious NCI-designation in 2015. Dr. Oh’s research interests include novel biomarkers and therapeutics in advanced prostate cancer. A leading investigator in the use of systemic treatments for prostate cancer, he has served as the principal investigator of multiple clinical trials in prostate and other GU cancers. In addition, he developed large clinical databases and specimen repositories for GU cancers at both Harvard and Mount Sinai which have enrolled over 8,000 patients with prostate, renal and bladder cancer over the past decade.
Dr. Oh has authored more than 250 original articles, reviews and book chapters on topics relating to prostate, renal, bladder and testicular cancers. He has edited 3 books on prostate cancer. He has served in key invited roles for the American Society of Clinical Oncology (ASCO), the American Cancer Society (ACS) and the American Urological Association (AUA), including the Guidelines Committee for Castration Resistant Prostate Cancer. In addition to reviewing for prominent journals such as the New England Journal of Medicine, Journal of Clinical Oncology, and Cancer, Dr. Oh co-edits “Testicular Cancer” for Up to Date and is Associate Editor of CA, A Cancer Journal for Clinicians. He was inducted into the prestigious American Society for Clinical Investigation (ASCI) and has been repeatedly selected as a Top Doctor in New York Magazine, Castle Connolly, Best Doctors and Super Doctors.
Dr. Oh received his MD from New York University School of Medicine. He completed his internship and residency in internal medicine at Brigham and Women’s Hospital in Boston. Dr. Oh subsequently completed a fellowship in medical oncology at the Dana-Farber Cancer Institute in 1997.
Prior to joining Mount Sinai in 2009, Dr. Oh was at the Dana-Farber Cancer Institute and Harvard Medical School in Boston, MA for 14 years. He served as Clinical Director of the Lank Center for Genitourinary Oncology and directed the Gelb Center for Translational Research. He was also the founding Chair of the Data and Safety Monitoring Committee for Phase I/II Trials at the Dana-Farber/Harvard Cancer Center.
DR. GIUSEPPE DEL PRIORE
Chief Medical Officer
Dr. Del Priore joined Tyme Inc. after serving as the National Director of Gynecologic Oncology for Cancer Treatment Centers of America (CTCA). He also serves as the Southeastern Regional Director. Prior to CTCA, Dr. Del Priore was Professor and Director of Gynecologic Oncology at the Indiana University School of Medicine in Indianapolis, where he directed its gynecologic oncology fellowship program and continues to teach. He previously also served as Director of Gynecologic Oncology at New York Downtown Hospital, Montefiore Medical Center, and Bellevue Hospital in New York City, as well as Assistant Director of Gynecologic Oncology at New York University School of Medicine. Giuseppe Del Priore, MD, MPH has been involved with drug, device and procedure development his entire career. He has participated and been on the advisory boards of studies for most major pharmaceutical companies. An industry KOL, his opinions have earned him invitations to present at the FDA and other regulatory agencies. His work has been reported on the front pages of the NY Times, WSJ and nearly every media outlet. He has been the principle investigator on several world firsts including breakthroughs in oncology, fertility and other areas of science. Dr. Del Priore remains a sought after clinician bringing relevant insights from actual patient challenges directly to the board room. Dr. Del Priore earned his Doctor of Medicine with Distinction in Research from State University of New York Downstate Medical Center in Brooklyn. He studied at The City University of New York’s Brooklyn College in a combined Bachelor of Arts/Doctor of Medicine Program, earning both degrees in seven years. Dr. Del Priore graduated magna cum laude with a Bachelor of Arts in Philosophy and was valedictorian of his medical school class. He received his Master of Public Health in Biostatistics and Epidemiology from the University of Illinois at Chicago and completed other training at Northwestern University and the University of Rochester. U.S. News and World Report named Dr. Del Priore one of its “Best Doctors” in 2011 and 2012.
He is an active researcher and prolific writer. He has authored and published more than 170 papers, book chapters, and abstracts and written three books. Dr. Del Priore has received two patents and has others pending. He has served on several committees and organizations, including current appointments at the Society of Gynecologic Oncologists; and previously the Gynecologic Oncology Group, a National Cancer Institute Cooperative Group. He is also an examiner for the American Osteopathic Association Board of Obstetrics and Gynecology, Gyn Oncology subspecialty section. In his free time, Dr. Del Priore has given back to his community by serving as a volunteer physicians part of the National Association of Free and Charitable Clinics; a volunteer firefighter in Westchester County, New York; an auxiliary police officer with the New York Police Department; and a volunteer ambulance driver with the Bay Ridge Ambulance Volunteer Organization.